Jason L. Walsh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jason L. Walsh has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Paul Banning
Oxford Heart Center, Oxford University Hospitals NHS Foundation Trust, United Kingdom (A.P.B.).
2 shared publications - Chu Miao
Oxford Heart Centre, Oxford University Hospitals NHS Trust, Oxford OX3 9DU, UK
2 shared publications - Giovanni Luigi De Maria
Acute Multidisciplinary Imaging and Interventional Centre (AMIIC), Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Oxford, United Kingdom
2 shared publications - Jonathan Vibhishanan
Oxford Heart Centre, Oxford University Hospitals NHS Trust, Oxford OX3 9DU, UK
2 shared publications - Rafail Angelos Kotronias
Department of Cardiovascular Medicine, University of Oxford, Oxford, UK
2 shared publications - Stefano Andreaggi
University of Verona, Italy
1 shared publication
Latest Publications
- Open Access
- 15 May 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (10) , 2923
Treatment and Care of Patients with ST-Segment Elevation Myocardial Infarction—What Challenges Remain after Three Decades of Primary Percutaneous Coronary Intervention?
Primary percutaneous coronary intervention (pPCI) has revolutionized the prognosis of ST-segment elevation myocardial infarction (STEMI) and is the gold standard treatment. As a result of its success, the number of pPCI centres has expanded worldwide. Despite decades of advancements, clinical outcomes in STEMI patients have plateaued. Out-of-hospital cardiac arrest and cardiogenic shock remain a major cause of high in-hospital mortality, whilst the growing burden of heart failure in long-term STEMI survivors presents a growing problem. Many elements aiming to optimize STEMI treatment are still subject to debate or lack sufficient evidence. This review provides an overview of the most contentious current issues in pPCI in STEMI patients, with an emphasis on unresolved questions and persistent challenges.
- 15 May 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (10) , 2923
Open AccessTreatment and Care of Patients with ST-Segment Elevation Myocardial Infarction—What Challenges Remain after Three Decades of Primary Percutaneous Coronary Intervention?
Primary percutaneous coronary intervention (pPCI) has revolutionized the prognosis of ST-segment elevation myocardial infarction (STEMI) and is the gold standard treatment. As a result of its success, the number of pPCI centres has expanded worldwide. Despite decades of advancements, clinical outcomes in STEMI patients have plateaued. Out-of-hospital cardiac arrest and cardiogenic shock remain a major cause of high in-hospital mortality, whilst the growing burden of heart failure in long-term STEMI survivors presents a growing problem. Many elements aiming to optimize STEMI treatment are still subject to debate or lack sufficient evidence. This review provides an overview of the most contentious current issues in pPCI in STEMI patients, with an emphasis on unresolved questions and persistent challenges.
- Open Access
- 23 April 2024
- Published by MDPI AG in Preprints.org
Treatment and Care of Patients with ST-Segment Elevation Myocardial Infarction. What Challenges Remain after Three Decades of Primary Percutaneous Coronary Intervention?
Primary percutaneous coronary intervention (pPCI) has revolutionized the prognosis of ST-segment ele-vation myocardial infarction (STEMI) and is the gold standard treatment. As a result of its success, the number of pPCI centres has expanded worldwide. Despite decades of advancements, clinical outcomes in STEMI patients have plateaued. Out-of-hospital car-diac arrest and cardiogenic shock remain a major cause of high in-hospital mortality, whilst the growing burden of heart failure in long-term STEMI survivors presents a growing problem. Many elements aiming to optimize STEMI treatment are still subject to debate or lack sufficient evidence. This review provides an overview of the most contentious current issues in pPCI in STEMI patients, with an emphasis on unresolved questions and persistent challenges.
- 23 April 2024
- Published by MDPI AG in Preprints.org
Open AccessTreatment and Care of Patients with ST-Segment Elevation Myocardial Infarction. What Challenges Remain after Three Decades of Primary Percutaneous Coronary Intervention?
Primary percutaneous coronary intervention (pPCI) has revolutionized the prognosis of ST-segment ele-vation myocardial infarction (STEMI) and is the gold standard treatment. As a result of its success, the number of pPCI centres has expanded worldwide. Despite decades of advancements, clinical outcomes in STEMI patients have plateaued. Out-of-hospital car-diac arrest and cardiogenic shock remain a major cause of high in-hospital mortality, whilst the growing burden of heart failure in long-term STEMI survivors presents a growing problem. Many elements aiming to optimize STEMI treatment are still subject to debate or lack sufficient evidence. This review provides an overview of the most contentious current issues in pPCI in STEMI patients, with an emphasis on unresolved questions and persistent challenges.